R&D Systems™ Recombinant Human LRRC4 Fc Chimera Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ 9375LR050

Catalog No. 93-75L-R050

Description

The Recombinant Human LRRC4 Fc Chimera Protein is derived from HEK293. The Recombinant Human LRRC4 Fc Chimera Protein has been validated for the following applications: Bioactivity.

Order Info

Ships at ambient temperature.

Specifications

• Accession Number: Q9HBW1
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS
• Molecular Weight (g/mol): 81 kDa
• Source: Human embryonic kidney cell,HEK293-derived human LRRC4 protein, (N-terminus) Human LRRC4 (Ala39-Lys527) Accession &Num; Q9HBW1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Regulatory Status: RUO
• Gene Alias: BAG, Brain Tumor Associated Protein LRRC4, Brain Tumor-Associated Protein BAG
• Product Type: Recombinant protein
• Species: Human
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining

• For Use With (Application): Bioactivity
• Gene ID (Entrez): 64101
• Quantity: 50μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Biological Activity: 2 to 12ng/mL
• Conjugate: Unconjugated
• Recombinant: Recombinant

For Research Use Only.